Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karim Fizazi

Showing results (1-10 of 445) with videos related to

Pageof 45
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 30, 2016
Biennial report on genitourinary cancersKarim Fizazi
Annales De Pathologie|November 9, 2010
[Metastasis from unknown primary neoplasm. The demands of the clinician in 2010 and in the future]Karim Fizazi
European Urology|July 17, 2012
Who should receive androgen deprivation therapy?Karim Fizazi
Bulletin Du Cancer|April 5, 2020
[Therapeutic options for genitourinary cancers during the epidemic period of COVID-19]Karim Fizazi,
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Nonhormone therapy for metastatic castration-resistant prostate cancer: chemotherapy, bone-targeted treatments, and othersKarim Fizazi
Bulletin Du Cancer|July 5, 2020
[Preface]Karim Fizazi
BJU International|July 24, 2009
Specific endothelin-A receptor antagonism for the treatment of advanced prostate cancerKarim Fizazi, Kurt Miller
La Revue Du Praticien|March 13, 2010
[Prostate tumors]Christophe Massard, Karim Fizazi
Critical Reviews in Oncology/Hematology|November 4, 2008
Carcinoma of unknown primary (CUP)Nicholas Pavlidis, Karim Fizazi
Critical Reviews in Oncology/Hematology|May 14, 2005
Cancer of unknown primary (CUP)Nicholas Pavlidis, Karim Fizazi
Pageof 45

Showing results (1-10 of 445) with videos related to

Sort By:
Pageof 45
European Journal of Cancer (Oxford, England : 1990)|August 30, 2016
Biennial report on genitourinary cancersKarim Fizazi
Annales De Pathologie|November 9, 2010
[Metastasis from unknown primary neoplasm. The demands of the clinician in 2010 and in the future]Karim Fizazi
European Urology|July 17, 2012
Who should receive androgen deprivation therapy?Karim Fizazi
Bulletin Du Cancer|April 5, 2020
[Therapeutic options for genitourinary cancers during the epidemic period of COVID-19]Karim Fizazi,
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Nonhormone therapy for metastatic castration-resistant prostate cancer: chemotherapy, bone-targeted treatments, and othersKarim Fizazi
Bulletin Du Cancer|July 5, 2020
[Preface]Karim Fizazi
BJU International|July 24, 2009
Specific endothelin-A receptor antagonism for the treatment of advanced prostate cancerKarim Fizazi, Kurt Miller
La Revue Du Praticien|March 13, 2010
[Prostate tumors]Christophe Massard, Karim Fizazi
Critical Reviews in Oncology/Hematology|November 4, 2008
Carcinoma of unknown primary (CUP)Nicholas Pavlidis, Karim Fizazi
Critical Reviews in Oncology/Hematology|May 14, 2005
Cancer of unknown primary (CUP)Nicholas Pavlidis, Karim Fizazi
Pageof 45